Skip to main content
NIH funding notice RFA-NS-20-014

Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed)

Closed on December 3, 2019.

Posted
September 5, 2019
Close date
December 3, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,754,296 in first-year total cost, median $877,148.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 BDCN-J (55)]2

Most frequent institutions

  1. BANNER HEALTH1
  2. CASE WESTERN RESERVE UNIVERSITY1
Competing awards under RFA-NS-20-014 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Blinded Comparison of Different Alpha-Synuclein Seeding Assays as Cutaneous Biomarkers of Lewy Body Dementias1R01NS118669-01ADLER, CHARLES HBEACH, THOMAS GKANTHASAMY, ANUMANTHA GOUNDERBANNER HEALTH, AZ$621,264ZRG1
2020Peripheral Tissue Biomarker for Premortem Diagnosis of Lewy Body Dementia1R01NS118760-01CHEN, SHU G.KRAUS, ALLISON LCASE WESTERN RESERVE UNIVERSITY, OH$1,133,032ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.